Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 4th edition, 372 pages

+ the daily Top 10

  Bladder Cancer

  Free Subscription

Articles published in BMC Cancer

Retrieve available abstracts of 51 articles:
HTML format

Single Articles

    May 2020
  1. RIPPING TM, Kiemeney LA, van Hoogstraten LMC, Witjes JA, et al
    Insight into bladder cancer care: study protocol of a large nationwide prospective cohort study (BlaZIB).
    BMC Cancer. 2020;20:455.
    PubMed     Abstract available

    March 2020
  2. ZHANG Y, Ou DH, Zhuang DW, Zheng ZF, et al
    In silico analysis of the immune microenvironment in bladder cancer.
    BMC Cancer. 2020;20:265.
    PubMed     Abstract available

  3. MORSCH R, Rose M, Maurer A, Cassataro MA, et al
    Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation.
    BMC Cancer. 2020;20:230.
    PubMed     Abstract available

  4. LATIFOVIC L, Villeneuve PJ, Parent ME, Kachuri L, et al
    Silica and asbestos exposure at work and the risk of bladder cancer in Canadian men: a population-based case-control study.
    BMC Cancer. 2020;20:171.
    PubMed     Abstract available

    January 2020
  5. SCHMID SC, Koll FJ, Rodel C, Maisch P, et al
    Radiation therapy before radical cystectomy combined with immunotherapy in locally advanced bladder cancer - study protocol of a prospective, single arm, multicenter phase II trial (RACE IT).
    BMC Cancer. 2020;20:8.
    PubMed     Abstract available

    December 2019
  6. WANG Z, Liu X, Liu X, Sun H, et al
    UPLC-MS based urine untargeted metabolomic analyses to differentiate bladder cancer from renal cell carcinoma.
    BMC Cancer. 2019;19:1195.
    PubMed     Abstract available

    November 2019
  7. BOURN J, Rathore K, Donnell R, White W, et al
    Detection of carcinogen-induced bladder cancer by fluorocoxib A.
    BMC Cancer. 2019;19:1152.
    PubMed     Abstract available

  8. MOLENAAR RJ, van Hattum JW, Brummelhuis IS, Oddens JR, et al
    Study protocol of a phase II clinical trial of oral metformin for the intravesical treatment of non-muscle invasive bladder cancer.
    BMC Cancer. 2019;19:1133.
    PubMed     Abstract available

  9. ZHANG J, Wang Y, Weng H, Wang D, et al
    Management of non-muscle-invasive bladder cancer: quality of clinical practice guidelines and variations in recommendations.
    BMC Cancer. 2019;19:1054.
    PubMed     Abstract available

    October 2019
  10. ALBARAKATI N, Khayyat D, Dallol A, Al-Maghrabi J, et al
    The prognostic impact of GSTM1/GSTP1 genetic variants in bladder Cancer.
    BMC Cancer. 2019;19:991.
    PubMed     Abstract available

    September 2019
  11. YUK HD, Jeong CW, Kwak C, Kim HH, et al
    Clinical outcomes of muscle invasive bladder Cancer according to the BASQ classification.
    BMC Cancer. 2019;19:897.
    PubMed     Abstract available

    August 2019
  12. SASSENBERG M, Droop J, Schulz WA, Dietrich D, et al
    Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
    BMC Cancer. 2019;19:806.
    PubMed     Abstract available

  13. FIORENTINO V, Pierconti F, Lenci N, Calicchia M, et al
    Urinary bladder leiomyosarcoma with osteoclast-like multinucleated giant cells: a case report.
    BMC Cancer. 2019;19:763.
    PubMed     Abstract available

    July 2019
  14. ZHANG L, Wu B, Zha Z, Qu W, et al
    Clinicopathological factors in bladder cancer for cancer-specific survival outcomes following radical cystectomy: a systematic review and meta-analysis.
    BMC Cancer. 2019;19:716.
    PubMed     Abstract available

    June 2019
  15. TRILLA-FUERTES L, Gamez-Pozo A, Prado-Vazquez G, Zapater-Moros A, et al
    Biological molecular layer classification of muscle-invasive bladder cancer opens new treatment opportunities.
    BMC Cancer. 2019;19:636.
    PubMed     Abstract available

  16. ZENG S, Liu A, Dai L, Yu X, et al
    Prognostic value of TOP2A in bladder urothelial carcinoma and potential molecular mechanisms.
    BMC Cancer. 2019;19:604.
    PubMed     Abstract available

    April 2019
  17. YASUI M, Kawahara T, Izumi K, Yao M, et al
    Androgen receptor mRNA expression is a predictor for recurrence-free survival in non-muscle invasive bladder cancer.
    BMC Cancer. 2019;19:331.
    PubMed     Abstract available

    March 2019
  18. PANG K, Zhang Z, Hao L, Shi Z, et al
    The ERH gene regulates migration and invasion in 5637 and T24 bladder cancer cells.
    BMC Cancer. 2019;19:225.
    PubMed     Abstract available

  19. LV S, Wang W, Wang H, Zhu Y, et al
    PPARgamma activation serves as therapeutic strategy against bladder cancer via inhibiting PI3K-Akt signaling pathway.
    BMC Cancer. 2019;19:204.
    PubMed     Abstract available

    February 2019
  20. GOULET CR, Champagne A, Bernard G, Vandal D, et al
    Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling.
    BMC Cancer. 2019;19:137.
    PubMed     Abstract available

    January 2019
  21. AL-HUSSEINI MJ, Kunbaz A, Saad AM, Santos JV, et al
    Trends in the incidence and mortality of transitional cell carcinoma of the bladder for the last four decades in the USA: a SEER-based analysis.
    BMC Cancer. 2019;19:46.
    PubMed     Abstract available

    December 2018
  22. MATHIS C, Lascombe I, Monnien F, Bittard H, et al
    Down-regulation of A-FABP predicts non-muscle invasive bladder cancer progression: investigation with a long term clinical follow-up.
    BMC Cancer. 2018;18:1239.
    PubMed     Abstract available

  23. RACIOPPI M, Di Gianfrancesco L, Ragonese M, Palermo G, et al
    ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk "BCG failure" non muscle invasive bladder cancer: 3 years follow-up outcomes.
    BMC Cancer. 2018;18:1224.
    PubMed     Abstract available

    November 2018
  24. WANG L, Chen S, Zhang Z, Zhang J, et al
    Suppressed OGT expression inhibits cell proliferation while inducing cell apoptosis in bladder cancer.
    BMC Cancer. 2018;18:1141.
    PubMed     Abstract available

  25. ZHOU T, Li HY, Xie WJ, Zhong Z, et al
    Association of Glutathione S-transferase gene polymorphism with bladder Cancer susceptibility.
    BMC Cancer. 2018;18:1088.
    PubMed     Abstract available

  26. WANG Z, Xiao H, Wei G, Zhang N, et al
    Low-dose Bacillus Calmette-Guerin versus full-dose for intermediate and high-risk of non-muscle invasive bladder cancer: a Markov model.
    BMC Cancer. 2018;18:1108.
    PubMed     Abstract available

    October 2018
  27. STEFFENSEN EH, Cary C, Jensen JB, Larsson H, et al
    Preadmission antidepressant use and bladder cancer: a population-based cohort study of stage at diagnosis, time to surgery, and surgical outcomes.
    BMC Cancer. 2018;18:1035.
    PubMed     Abstract available

    September 2018
  28. WIJBURG CJ, Michels CTJ, Oddens JR, Grutters JPC, et al
    Robot assisted radical cystectomy versus open radical cystectomy in bladder cancer (RACE): study protocol of a non-randomized comparative effectiveness study.
    BMC Cancer. 2018;18:861.
    PubMed     Abstract available

    June 2018
  29. LIU H, He W, Wang B, Xu K, et al
    MALBAC-based chromosomal imbalance analysis: a novel technique enabling effective non-invasive diagnosis and monitoring of bladder cancer.
    BMC Cancer. 2018;18:659.
    PubMed     Abstract available

  30. LIU Y, Wang H, Zhong J, Wu C, et al
    Decreased expression of SRY-box containing gene 30 is related to malignant phenotypes of human bladder cancer and correlates with poor prognosis.
    BMC Cancer. 2018;18:642.
    PubMed     Abstract available

    May 2018
  31. KWON WA, Joung JY, Lim J, Oh CM, et al
    Risk of second primary Cancer among bladder Cancer patients: a population-based cohort study in Korea.
    BMC Cancer. 2018;18:617.
    PubMed     Abstract available

  32. XIE H, Zhu Y, Zhang J, Liu Z, et al
    B4GALT1 expression predicts prognosis and adjuvant chemotherapy benefits in muscle-invasive bladder cancer patients.
    BMC Cancer. 2018;18:590.
    PubMed     Abstract available

    April 2018
  33. MAEDA S, Tomiyasu H, Tsuboi M, Inoue A, et al
    Comprehensive gene expression analysis of canine invasive urothelial bladder carcinoma by RNA-Seq.
    BMC Cancer. 2018;18:472.
    PubMed     Abstract available

    February 2018
  34. PULIDO M, Roubaud G, Cazeau AL, Mahammedi H, et al
    Safety and efficacy of temsirolimus as second line treatment for patients with recurrent bladder cancer.
    BMC Cancer. 2018;18:194.
    PubMed     Abstract available

  35. SEVERINO PF, Silva M, Carrascal M, Malagolini N, et al
    Oxidative damage and response to Bacillus Calmette-Guerin in bladder cancer cells expressing sialyltransferase ST3GAL1.
    BMC Cancer. 2018;18:198.
    PubMed     Abstract available

    December 2017
  36. ZHANG Z, Zhang G, Gao Z, Li S, et al
    Comprehensive analysis of differentially expressed genes associated with PLK1 in bladder cancer.
    BMC Cancer. 2017;17:861.
    PubMed     Abstract available

    November 2017
  37. HUEBNER D, Rieger C, Bergmann R, Ullrich M, et al
    An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice: influence of mouse strain, tumor cell count, dwell time and bladder pretreatment.
    BMC Cancer. 2017;17:790.
    PubMed     Abstract available

  38. TAN WS, Feber A, Dong L, Sarpong R, et al
    DETECT I & DETECT II: a study protocol for a prospective multicentre observational study to validate the UroMark assay for the detection of bladder cancer from urinary cells.
    BMC Cancer. 2017;17:767.
    PubMed     Abstract available

  39. TOLKACH Y, Stahl AF, Niehoff EM, Zhao C, et al
    YRNA expression predicts survival in bladder cancer patients.
    BMC Cancer. 2017;17:749.
    PubMed     Abstract available

    September 2017
  40. NEUZILLET Y, Chapeaublanc E, Krucker C, De Koning L, et al
    IGF1R activation and the in vitro antiproliferative efficacy of IGF1R inhibitor are inversely correlated with IGFBP5 expression in bladder cancer.
    BMC Cancer. 2017;17:636.
    PubMed     Abstract available

    June 2017
  41. PENG D, Gong YQ, Hao H, He ZS, et al
    Preoperative Prognostic Nutritional Index is a Significant Predictor of Survival with Bladder Cancer after Radical Cystectomy: a retrospective study.
    BMC Cancer. 2017;17:391.
    PubMed     Abstract available

    May 2017
  42. TEYSSONNEAU D, Daste A, Dousset V, Hoepffner JL, et al
    Metastatic non-muscle invasive bladder cancer with meningeal carcinomatosis: case report of an unexpected response.
    BMC Cancer. 2017;17:323.
    PubMed     Abstract available

  43. FONTEYNE V, Dirix P, Junius S, Rammant E, et al
    Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer: a phase II trial.
    BMC Cancer. 2017;17:308.
    PubMed     Abstract available

    April 2017
  44. KAO YT, Wu CH, Wu SY, Lan SH, et al
    Arsenic treatment increase Aurora-A overexpression through E2F1 activation in bladder cells.
    BMC Cancer. 2017;17:277.
    PubMed     Abstract available

  45. LAVERY HJ, Zaharieva B, McFaddin A, Heerema N, et al
    A prospective comparison of UroVysion FISH and urine cytology in bladder cancer detection.
    BMC Cancer. 2017;17:247.
    PubMed     Abstract available

    March 2017
  46. MIYAKE M, Morizawa Y, Hori S, Marugami N, et al
    Clinical impact of postoperative loss in psoas major muscle and nutrition index after radical cystectomy for patients with urothelial carcinoma of the bladder.
    BMC Cancer. 2017;17:237.
    PubMed     Abstract available

    February 2017
  47. DYSHLOVOY SA, Madanchi R, Hauschild J, Otte K, et al
    The marine triterpene glycoside frondoside A induces p53-independent apoptosis and inhibits autophagy in urothelial carcinoma cells.
    BMC Cancer. 2017;17:93.
    PubMed     Abstract available

    January 2017
  48. BAI Y, Wang X, Yang Y, Tang Y, et al
    Parity and bladder cancer risk: a dose-response meta-analysis.
    BMC Cancer. 2017;17:31.
    PubMed     Abstract available

    November 2016
  49. KONG C, Zhan B, Piao C, Zhang Z, et al
    Overexpression of UNC5B in bladder cancer cells inhibits proliferation and reduces the volume of transplantation tumors in nude mice.
    BMC Cancer. 2016;16:892.
    PubMed     Abstract available

  50. BENHAMOU S, Bonastre J, Groussard K, Radvanyi F, et al
    A prospective multicenter study on bladder cancer: the COBLAnCE cohort.
    BMC Cancer. 2016;16:837.
    PubMed     Abstract available

    January 2016
  51. ANANTHARAMAN A, Friedlander T, Lu D, Krupa R, et al
    Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients.
    BMC Cancer. 2016;16:744.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.